Accuray/$ARAY
1D1W1MYTD1Y5YMAX
Capital at risk
About Accuray
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.
- Ticker
- $ARAY
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 809
- Headquarters
- Madison, United States
- Website
- www.accuray.com
Accuray Metrics
BasicAdvanced
$31M
-
-$0.40
1.39
-
Price and volume
Market cap
$31M
Beta
1.39
52-week high
$2.10
52-week low
$0.22
Average daily volume
1.1M
Financial strength
Current ratio
1.503
Quick ratio
0.661
Long term debt to equity
417.607
Total debt to equity
440.955
Interest coverage (TTM)
-0.31%
Profitability
EBITDA (TTM)
-2.329
Gross margin (TTM)
27.73%
Net profit margin (TTM)
-12.24%
Operating margin (TTM)
-2.56%
Effective tax rate (TTM)
-4.12%
Revenue per employee (TTM)
$500,000
Management effectiveness
Return on assets (TTM)
-1.40%
Return on equity (TTM)
-80.08%
Valuation
Price to revenue (TTM)
0.08
Price to book
0.75
Price to tangible book (TTM)
-1.93
Price to free cash flow (TTM)
-1.668
Free cash flow yield (TTM)
-59.94%
Free cash flow per share (TTM)
-0.157
Growth
Revenue change (TTM)
-12.34%
Earnings per share change (TTM)
2,491.18%
3-year revenue growth (CAGR)
-3.52%
10-year revenue growth (CAGR)
0.08%
3-year earnings per share growth (CAGR)
60.07%
10-year earnings per share growth (CAGR)
2.39%
What the Analysts think about Accuray
Analyst ratings (Buy, Hold, Sell) for Accuray stock.
Analyst projections of the future price of Accuray stock.
Accuray Financial Performance
Revenues and expenses
Accuray Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.